BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21811181)

  • 1. Osteonecrosis of femoral head treated with alendronate in a 14-year-old boy: a case report.
    Cheon SH; Oh CW; Park SK
    J Pediatr Orthop B; 2012 May; 21(3):260-3. PubMed ID: 21811181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does alendronate prevent collapse in osteonecrosis of the femoral head?
    Nishii T; Sugano N; Miki H; Hashimoto J; Yoshikawa H
    Clin Orthop Relat Res; 2006 Feb; 443():273-9. PubMed ID: 16462451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate treatment in osteonecrosis of the femoral head].
    Nishii T; Hashimoto J; Yoshikawa H; Miki H; Sugano N
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():537-41. PubMed ID: 18161162
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of distortion of vascular deprivation-induced osteonecrosis of the rat femoral head by treatment with alendronate.
    Peled E; Bejar J; Zinman C; Boss JH; Reis DN; Norman D
    Arch Orthop Trauma Surg; 2009 Feb; 129(2):275-9. PubMed ID: 18523789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.
    Agarwala S; Shah S; Joshi VR
    J Bone Joint Surg Br; 2009 Aug; 91(8):1013-8. PubMed ID: 19651826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study.
    Chen CH; Chang JK; Lai KA; Hou SM; Chang CH; Wang GJ
    Arthritis Rheum; 2012 May; 64(5):1572-8. PubMed ID: 22127729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate.
    Arai R; Takahashi D; Inoue M; Irie T; Asano T; Konno T; Terkawi MA; Onodera T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Jan; 18(1):24. PubMed ID: 28103867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy increases bone density in osteonecrosis of the femoral head in canines.
    Bowers JR; Dailiana ZH; McCarthy EF; Urbaniak JR
    J Surg Orthop Adv; 2004; 13(4):210-6. PubMed ID: 15691182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits.
    Hofstaetter JG; Wang J; Yan J; Glimcher MJ
    Osteoarthritis Cartilage; 2009 Mar; 17(3):362-70. PubMed ID: 18786840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years.
    Agarwala S; Shah SB
    J Arthroplasty; 2011 Oct; 26(7):1128-34. PubMed ID: 21256699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate.
    Wang CJ; Wang FS; Yang KD; Huang CC; Lee MS; Chan YS; Wang JW; Ko JY
    Arch Orthop Trauma Surg; 2008 Sep; 128(9):901-8. PubMed ID: 18060419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous bisphosphonate therapy for children who have a traumatic fracture neck of femur and osteonecrosis: a case report.
    Pisuitthanakan S; Premprabha T
    J Med Assoc Thai; 2012 Feb; 95(2):275-8. PubMed ID: 22435260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.
    Lai KA; Shen WJ; Yang CY; Shao CJ; Hsu JT; Lin RM
    J Bone Joint Surg Am; 2005 Oct; 87(10):2155-9. PubMed ID: 16203877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study.
    Kang P; Pei F; Shen B; Zhou Z; Yang J
    Joint Bone Spine; 2012 Jan; 79(1):67-72. PubMed ID: 21742531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
    BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral alendronate in osteogenesis imperfecta.
    Unal E; Abaci A; Bober E; Buyukgebiz A
    Indian Pediatr; 2005 Nov; 42(11):1158-60. PubMed ID: 16340059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
    Little DG; Kim HK
    J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core decompression and alendronate treatment of the osteonecrotic rat femoral head: computer-assisted analysis.
    Peled E; Bejar J; Barak M; Orion E; Norman D
    Int J Exp Pathol; 2013 Jun; 94(3):212-6. PubMed ID: 23594399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Efficacy of Alendronate for Preventing Collapse of Femoral Head in Adult Patients with Nontraumatic Osteonecrosis".
    Yuan H
    Biomed Res Int; 2015; 2015():354109. PubMed ID: 26064902
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of alendronate for preventing collapse of femoral head in adult patients with nontraumatic osteonecrosis.
    Hong YC; Luo RB; Lin T; Zhong HM; Shi JB
    Biomed Res Int; 2014; 2014():716538. PubMed ID: 25535614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.